The Gut and Skin Microbiome in Alopecia: Associations and Interventions
- PMID: 37915336
- PMCID: PMC10617895
The Gut and Skin Microbiome in Alopecia: Associations and Interventions
Abstract
Objective: This review examines the current literature on the gut-skin connection in alopecia and summarizes interventions that impact hair growth by modulation of the gut or skin microbiome.
Methods: PubMed searches were done to assess studies of the gut and skin microbiome and forms of alopecia including, alopecia areata (AA), androgenic alopecia (AGA), alopecia universalis (AU), central centrifugal cicatricial alopecia (CCCA) and lichen planopilaris (LPP). Filters were applied for human and animal studies. Articles not translated to English and studies assessing supplemental therapies on alopecia were excluded.
Results: There is evidence that scalp, hair follicle, and gut microbiome alterations are associated with various types of alopecia. There is potential in the use of interventions targeting microbiome dysbiosis, including fecal transplants and probiotics.
Limitations: This field of study still requires more high-quality research and studies with larger participant populations.
Conclusion: Dysbiosis on the scalp, within the hair follicle and the gut seem to have a role in the pathophysiology of various forms of alopecia. There is evidence that interventions targeting dysbiosis may have potential in the treatment and management of hair loss. Further studies are needed to establish a direct connection and to clarify specific effects of these interventions.
Keywords: Alopecia; dysbiosis; hair loss; microbiome; probiotic.
Copyright © 2023. Matrix Medical Communications. All rights reserved.
Conflict of interest statement
DISCLOSURES: Dr. Maloh serves as a consultant for Codex Labs Corp. Dr. Sivamani serves as a scientific advisor for LearnHealth, Arbonne, and Codex Labs and has served as a consultant or speaker for Burt’s Bees, Novozymes, Biogena, Novartis, Sanofi, Bristol Myers Squibb, Pfizer, Nutrafol, Galderma, Novartis, Abbvie, Leo, UCB, Sun and Regeneron Pharmaceuticals.
References
-
- Kosiewicz MM et al. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett, 2014;588(22):4195–4206. - PubMed
-
- Safina DD, Abdulkhakov SR, Odintsova AK Clinical case of a combination of ulcerative colitis and alopecia areata. 2013. pp. p. 92–96. Experimental & Clinical Gastroenterology. - PubMed
-
- Patel KV et al. Hair loss in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19(8):1753–1763. - PubMed
-
- Sobolewska-Włodarczyk A. et al. Alopecia areata in patients with inflammatory bowel disease: an overview. Folia Med Cracov. 2016. 56 15-12 - PubMed
-
- Muller SA, Winkelmann RK. ALOPECIA AREATA. AN EVALUATION OF 736 PATIENTS. Arch Dermatol. 1963;88:290–297. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous